Amarin Corp Plc (AMRN)

[Number sleven]

CBB, It can't be a priority at the moment. That's a financial issue. The studies being conducted right now are looking at icosapent ethyl as a primary treatment. From memory I think the metastasized breast cancer study might have a secondary drug involved. The CVD indication that we have is worth more than most understand. These other indications will play out over time. I don't think this company is up for sale at the moment.
Sleven,